Alterity Therapeutics (ATHE) Cash from Operations (2009 - 2020)

Alterity Therapeutics' Cash from Operations history runs 8 years deep, the most recent figure standing at 6181351.89 for Q2 2020.

• In Q2 2020, Cash from Operations rose 36.76% year-over-year to 6181351.89; the TTM figure through Jun 2020 stood at 22903655.12 (down 44.0% YoY), while the FY2025 annual figure was 7333759.44, up 11.72% from the prior year.
• Cash from Operations was 6181351.89 for Q2 2020 at Alterity Therapeutics, down from 1766470.98 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 47278.38 in Q2 2018 to a low of 9774963.11 in Q2 2019.
• Historically, Cash from Operations has averaged 3807101.07 across 5 years, with a median of 4405908.68 in 2017.
• The sharpest annual moves came in 2018 and 2019: Cash from Operations jumped 98.93% in 2018, then plunged 20575.33% in 2019.
• A 5-year view of Cash from Operations shows it stood at 465813.11 in 2016, then sank by 93.6% to 901823.06 in 2017, then tumbled by 474.49% to 5180869.14 in 2018, then jumped by 65.9% to 1766470.98 in 2019, then plunged by 249.93% to 6181351.89 in 2020.
• The last three Cash from Operations figures came in at 6181351.89 (Q2 2020), 1766470.98 (Q4 2019), and 9774963.11 (Q2 2019), per Business Quant data.